Liquid Dosage
Therapeutical Proteins
Protein-based therapeutics are increasingly being developed as new chemical entities in the pharmaceutical and life science industries. Unlike small molecules, which are typically synthesized using chemical processes, most proteins need to be processed in living systems, mostly by recombinant DNA technology. The proteins can then be produced in their functional form (quaternary structure), rather than by microbial biosynthesis (bacteria/yeast), substantially reducing the downstream stages of the process.
The GEA Advantage
As the demand for large-volume products increases, so does the requirement for higher capacity reactors (up to 20,000 L) to realize economies of scale. GEA has responded to the changing needs of biopharmaceutical manufacturers and developed improved technology solutions to optimize both upstream and, with increasing titers, downstream processing, in terms of time and cost efficiency.
Based on its history of innovation and process development, GEA has a thorough working knowledge of therapeutic protein production and has used this competence to design better media and feeding strategies, optimize the fermentation stage and enhance physicochemical conditions during the manufacturing process.
A leading international supplier of integrated process systems, our extensive portfolio of products, technologies and services includes standard and customized fermenters, separators and entire production lines, as well as plant for the production, storage and distribution of clean utilities. Systems for the preparation of media, fluid management, cell cultivation and purification are also part of our global scope of supply.
As a competent manufacturer of complete plant for the life science industries, GEA is a full-service provider of solutions that meet your exact requirements and specifications. From planning, development and installation to qualification and maintenance, our experienced engineers will collaborate with your project team to supply innovative and efficient process solutions for your applications.
Producten & technologieën
Weergegeven 4 van 29
Afsluitkleppen
Aseptische afsluitkleppen met enkele zitting worden gebruikt voor het gecontroleerd openen en sluiten van pijplijnen in UltraClean- en aseptische verwerkingsinstallaties.
Analytische, in-line besturings- & meetapparatuur
Door procesbewaking met behulp van online analysesystemen te combineren met vaste principes van procesengineering en geavanceerde procesmodelleringstechnieken, kunnen processen actief bestuurd worden om invoervariaties te compenseren.
Aseptisch piggingsysteem
Met een aseptisch piggingsysteem kunnen waardevolle producten uit de productleiding worden teruggewonnen. Aangedreven door steriel water of perslucht duwt de 'pig' het product uit de leiding. De achterblijvende productresten aan de binnenkant van de productleiding kan vervolgens via CIP worden verwijderd.
Bemonsteringskleppen
Aseptische bemonsteringskleppen worden gebruikt voor veilige monstername in UltraClean- en aseptische verwerkingsinstallaties
GEA-inzichten
At the table for … new food: Crafting the future of our food
Coffee, cocoa, milk, meat, fish and eggs – these daily staples rely heavily on intensive agriculture. With the rise of new food technologies, we have more sustainable alternatives. We sat down with Dr. Reimar Gutte, Senior Vice...
Innovating patient care with aseptic spray drying
At GEA, our commitment to engineering for a better world fuels our pursuit of innovative solutions that enhance patient care and safety. One of our most promising ventures in recent years is aseptic spray drying – a technology...
Lecithine: wanneer een bijproduct de hoofdrol gaat spelen
Lecithine heeft een speciaal plekje in het hart van GEA Product Sales Manager Patrick Schürmann. De veelzijdige stof is van een ondersteunende rol in de raffinage van eetbare olie uitgegroeid tot de ster van de sterk concurrerende...
